Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Operating income of Astellas Pharma Inc. from fiscal year 2008 to 2017
(in billion Japanese yen)
Astellas Pharma's operating profit FY 2008-2017
This statistic depicts the operating income of the pharmaceutical company Astellas Pharma Inc. from fiscal year 2008 to 2017. In fiscal year 2017, Astellas Pharma's operating profit amounted to approximately 267 billion Japanese yen, slightly decreased from around 275 billion yen in the previous fiscal year.
Operating income of Astellas Pharma Inc. from fiscal year 2008 to 2017
(in billion Japanese yen)
Operating income in billion Japanese yen
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

September 2018

Region

Japan

Survey time period

fiscal year 2008 to 2017; the Japanese fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Special properties

consolidated data

Supplementary notes

Astellas Pharma Inc. has adopted International Financial Reporting Standards (IFRS) since the fiscal year ended March 31, 2014. Figures up to fiscal year ended March 31, 2014, are based on Japanese generally accepted accounting principles (J-GAAP).

1 Japanese yen equals 0.00881 U.S. dollars or 0.00778 euros as of December 2018.

Astellas Pharma's operating profit FY 2008-2017
This statistic depicts the operating income of the pharmaceutical company Astellas Pharma Inc. from fiscal year 2008 to 2017. In fiscal year 2017, Astellas Pharma's operating profit amounted to approximately 267 billion Japanese yen, slightly decreased from around 275 billion yen in the previous fiscal year.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.